ImmuPharma’s McCarthy on phase III Lupuzor™ trials

3rd February 2015 - 4:08 pm

Tim McCarthy, Chairman of ImmuPharma (LON:IMM), discusses the upcoming Phase III clinical trial of Lupuzor.

Share this article